Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub

Therapeutic Classification

statin Registry

Clinical reference for statin medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (statin)

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.

MedicationTherapeutic ClassMaternal Safety

ALTOPREV

Comprehensive clinical and safety monograph for ALTOPREV (ALTOPREV).

HMG-CoA Reductase Inhibitor (Statin)

caution

ATORVALIQ

Comprehensive clinical and safety monograph for ATORVALIQ (ATORVALIQ).

Statin

caution

ATORVASTATIN CALCIUM

Comprehensive clinical and safety monograph for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM).

Statin

caution

BARSTATIN 100

Comprehensive clinical and safety monograph for BARSTATIN 100 (BARSTATIN 100).

Statin

caution

BAYCOL

Comprehensive clinical and safety monograph for BAYCOL (BAYCOL).

Statin

caution

CRESTOR

Comprehensive clinical and safety monograph for CRESTOR (CRESTOR).

Statin

caution

EZETIMIBE AND SIMVASTATIN

Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.

Statin

avoid

FLOLIPID

Comprehensive clinical and safety monograph for FLOLIPID (FLOLIPID).

HMG-CoA Reductase Inhibitor (Statin)

caution

FLUVASTATIN SODIUM

Can increase the effects of warfarin and other drugs metabolized by CYP2C9 Can cause myopathy and rhabdomyolysis.

Statin

avoid

KOROSTATIN

Comprehensive clinical and safety monograph for KOROSTATIN (KOROSTATIN).

HMG-CoA Reductase Inhibitor (Statin)

caution

LANREOTIDE ACETATE

Comprehensive clinical and safety monograph for LANREOTIDE ACETATE (LANREOTIDE ACETATE).

Somatostatin Analog

caution

LOVASTATIN

Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.

Statin

avoid

MEVACOR

Comprehensive clinical and safety monograph for MEVACOR (MEVACOR).

HMG-CoA Reductase Inhibitor (Statin)

caution

MYCAPSSA

Comprehensive clinical and safety monograph for MYCAPSSA (MYCAPSSA).

Somatostatin Analog

caution

OCTREOTIDE ACETATE

Comprehensive clinical and safety monograph for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE).

Somatostatin analog

caution

OCTREOTIDE ACETATE PRESERVATIVE FREE

Comprehensive clinical and safety monograph for OCTREOTIDE ACETATE PRESERVATIVE FREE (OCTREOTIDE ACETATE PRESERVATIVE FREE).

Somatostatin analog

caution

OMTRYG

Comprehensive clinical and safety monograph for OMTRYG (OMTRYG).

HMG-CoA Reductase Inhibitor (Statin)

caution

PITAVASTATIN CALCIUM

Cyclosporine may increase levels Can cause myopathy and rhabdomyolysis.

Statin

avoid

PRAVASTATIN SODIUM

Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.

Statin

avoid

PRAVIGARD PAC (COPACKAGED)

Comprehensive clinical and safety monograph for PRAVIGARD PAC (COPACKAGED) (PRAVIGARD PAC (COPACKAGED)).

Antiplatelet/Statin Combination

caution

ROSUVASTATIN CALCIUM

Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.

Statin

avoid

ROSUVASTATIN ZINC

Not significantly metabolized by CYP450 enzymes fewer interactions Can cause myopathy and rhabdomyolysis.

Statin

avoid

SANDOSTATIN

Comprehensive clinical and safety monograph for SANDOSTATIN (SANDOSTATIN).

Somatostatin Analog

caution

SANDOSTATIN LAR

Comprehensive clinical and safety monograph for SANDOSTATIN LAR (SANDOSTATIN LAR).

Somatostatin Analog

caution

SIGNIFOR

Comprehensive clinical and safety monograph for SIGNIFOR (SIGNIFOR).

Somatostatin Analog

caution

SIGNIFOR LAR KIT

Comprehensive clinical and safety monograph for SIGNIFOR LAR KIT (SIGNIFOR LAR KIT).

Somatostatin Analog

caution

SIMVASTATIN

Strong CYP3A4 inhibitors (eg itraconazole) can significantly increase levels and risk of myopathy Can cause myopathy and rhabdomyolysis.

Statin

avoid

SOMATULINE DEPOT

Comprehensive clinical and safety monograph for SOMATULINE DEPOT (SOMATULINE DEPOT).

Somatostatin Analog

caution

VYTORIN

Comprehensive clinical and safety monograph for VYTORIN (VYTORIN).

Lipid-lowering Combination (Statin + Ezetimibe)

caution

ZOCOR

Comprehensive clinical and safety monograph for ZOCOR (ZOCOR).

Statin Antihyperlipidemic

caution

ZYPITAMAG

Comprehensive clinical and safety monograph for ZYPITAMAG (ZYPITAMAG).

Statin

caution